A Neurotoxic Glycerophosphocholine Impacts PtdIns-4, 5-Bisphosphate and TORC2 Signaling by Altering Ceramide Biosynthesis in Yeast

Unbiased lipidomic approaches have identified impairments in glycerophosphocholine second messenger metabolism in patients with Alzheimer's disease. Specifically, we have shown that amyloid-β42 signals the intraneuronal accumulation of PC( O -16:0/2:0) which is associated with neurotoxicity. Similar to neuronal cells, intracellular accumulation of PC( O -16:0/2:0) is also toxic to Saccharomyces cerevisiae , making yeast an excellent model to decipher the pathological effects of this lipid. We previously reported that phospholipase D, a phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P 2 )-binding protein, was relocalized in response to PC( O -16:0/2:0), suggesting that this neurotoxic lipid may remodel lipid signaling networks. Here we show that PC( O -16:0/2:0) regulates the distribution of the PtdIns(4)P 5-kinase Mss4 and its product PtdIns(4,5)P 2 leading to the formation of invaginations at the plasma membrane (PM). We further demonstrate that the effects of PC( O -16:0/2:0) on the distribution of PM PtdIns(4,5)P 2 pools are in part mediated by changes in the biosynthesis of long chain bases (LCBs) and ceramides. A combination of genetic, biochemical and cell imaging approaches revealed that PC( O -16:0/2:0) is also a potent inhibitor of signaling through the Target of rampamycin complex 2 (TORC2). Together, these data provide mechanistic insight into how specific disruptions in phosphocholine second messenger metabolism associated with Alzheimer's disease may trigger larger network-wide disruptions in ceramide and phosphoinositide second messenger biosynthesis and signaling which have been previously implicated in disease progression.